Showing 2211-2220 of 4065 results for "".
Progress and Practical Limits with AI in Psoriatic Arthritis
https://reachmd.com/programs/Audioabstracts/progress-practical-limits-ai-psoriatic-arthritis/51047/Artificial intelligence is reshaping the landscape of psoriatic arthritis, offering new tools to improve diagnosis, risk assessment, and treatment response prediction. Hear Ryan Quigley discuss a narrative review that looked at emerging AI innovations in rheumatology and how they may enhance care foWhy Vaccination Strategy Matters: Evidence from COVID-19 Modeling
https://reachmd.com/programs/clinicians-roundtable/vaccination-strategy-covid-19-modeling/48834/The Case for Doing the Hard Thing
https://reachmd.com/topics/practice-development/the-case-for-doing-the-hard-thing/49010/Analyzing the Clinical Evidence
https://reachmd.com/topics/sponsored-articles/analyzing-the-clinical-evidence/49015/Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
https://reachmd.com/programs/cme/breaking-down-the-benchmarks-pivotal-data-on-first-line-cdk46-inhibitors/39798/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Spotlight on Latin America: Closing the Gap
https://reachmd.com/programs/cme/spotlight-on-latin-america-closing-the-gap/39809/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.GA Case Compendium: Patient Education, Advanced Technologies, and Timely Referrals Are Crucial in Geographic Atrophy
https://reachmd.com/resources/geographic-atrophy-case-compendium/ga-case-compendium-patient-education-advance-technologies-and-timely-referrals-are-crucial-in-geographic-atrophy/48920/Managing PNH Patients: Addressing the Unmet Needs
https://reachmd.com/programs/project-oncology/managing-pnh-patients-addressing-the-unmet-needs/48881/What are the current knowledge gaps when it comes to managing patients with PNH? Here's what you need to know.Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial
https://reachmd.com/clinical-practice/cardiology/evolocumab-in-patients-at-high-cardiovascular-risk-without-prior-mi-or-stroke-primary-results-of-the-vesalius-cv-trial/39889/Explore VESALIUS-CV trial results on evolocumab for cardiovascular risk reduction in patients without prior MI or stroke who are at high cardiovascular risk.Diuretic Response in the ICU: A Practical Predictor of Renal Trajectory
https://reachmd.com/programs/clinicians-roundtable/diuretic-response-in-the-icu-a-practical-predictor-of-renal-trajectory/37219/